Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38052
CAS Number:
151767-02-1
Montelukast sodium hydrate
Purity:
≥ 98% (HPLC)
Documents
$73.71 /200MG
Pack Size Availability Price
Request Bulk Quote
Product Information

Montelukast sodium hydrate is a potent leukotriene receptor antagonist widely utilized in the management of asthma and allergic rhinitis. This compound works by inhibiting the action of leukotrienes, which are inflammatory mediators that contribute to bronchoconstriction and mucus production. As a result, Montelukast sodium hydrate is effective in reducing airway inflammation and improving respiratory function, making it a valuable option for patients suffering from chronic respiratory conditions.

In addition to its primary applications in respiratory health, Montelukast sodium hydrate has shown promise in various research settings, including studies on exercise-induced bronchoconstriction and allergic responses. Its ability to provide relief from symptoms without the sedative effects commonly associated with other medications makes it a preferred choice among healthcare professionals. With its favorable safety profile and ease of administration, Montelukast sodium hydrate continues to be a critical component in the therapeutic arsenal against asthma and allergies.

CAS Number
151767-02-1
Purity
≥ 98% (HPLC)
Molecular Formula
C35H35ClNNaO3S·xH2O
Molecular Weight
626.18
MDL Number
MFCD00931431
PubChem ID
53394937
Appearance
Yellow to brrown powder
Optical Rotation
[a]D20 = 95 - 105 ° (C=1 in MeOH)
Conditions
Store at 2 - 8 °C
General Information
CAS Number
151767-02-1
Purity
≥ 98% (HPLC)
Molecular Formula
C35H35ClNNaO3S·xH2O
Molecular Weight
626.18
MDL Number
MFCD00931431
PubChem ID
53394937
Appearance
Yellow to brrown powder
Optical Rotation
[a]D20 = 95 - 105 ° (C=1 in MeOH)
Conditions
Store at 2 - 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Montelukast sodium hydrate is widely utilized in research focused on:

  • Asthma Management: This compound is primarily used as a medication to prevent asthma attacks by blocking leukotrienes, which are substances in the body that cause inflammation and bronchoconstriction. It is particularly beneficial for patients with exercise-induced bronchoconstriction.
  • Allergy Treatment: It is effective in alleviating symptoms of allergic rhinitis, such as sneezing and runny nose, making it a valuable option for individuals suffering from seasonal allergies.
  • Pediatric Applications: Montelukast sodium hydrate is safe for use in children, providing a non-steroidal option for managing asthma and allergies, which is crucial for parents looking for effective treatments without the side effects associated with steroids.
  • Chronic Obstructive Pulmonary Disease (COPD): Research has shown that this compound can be beneficial in managing symptoms of COPD, offering an alternative treatment avenue for patients with chronic respiratory issues.
  • Research in Inflammation: Beyond its clinical applications, montelukast sodium hydrate is also studied in laboratories for its potential effects on various inflammatory conditions, providing insights that could lead to new therapeutic strategies.

Citations